Chargement en cours...
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
BACKGROUND: Mutations in BRCA1 and BRCA2 are associated with better survival in ovarian cancer (OC) patients due to a better response to platinum-based chemotherapy. However, the impact of the BRCA1/2 mRNA-expression is not well characterized in OC. PATIENTS AND METHODS: We investigated BRCA1/2 mRNA...
Enregistré dans:
| Publié dans: | Br J Cancer |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group UK
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6173779/ https://ncbi.nlm.nih.gov/pubmed/30111871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0217-4 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|